Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Erica L Mayer

Showing results (71-80 of 120) with videos related to

Pageof 12
Sort By:
Future Oncology (London, England)|April 18, 2023
Design of SERENA-6, a phase III switching trial of camizestrant in <i>ESR1</i>-mutant breast cancer during first-line treatmentNicholas Turner, Cynthia Huang-Bartlett, Kevin Kalinsky, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 20, 2014
Circulating tumor cell analysis in metastatic triple-negative breast cancersMark Jesus M Magbanua, Lisa A Carey, Amy DeLuca, et al.
Journal of Surgical Oncology|July 10, 2016
Immediate breast reconstruction following mastectomy in pregnant women with breast cancerDiana L Caragacianu, Erica L Mayer, Yoon S Chun, et al.
Journal of the American College of Cardiology|June 27, 2015
Cardiovascular Health of Patients With Cancer and Cancer Survivors: A Roadmap to the Next LevelAna Barac, Gillian Murtagh, Joseph R Carver, et al.
Breast Cancer Research and Treatment|March 7, 2026
A phase II study of atezolizumab in combination with stereotactic radiation for patients with triple-negative breast cancer and brain metastasisAntonio Giordano, Noah Graham, Ayal A Aizer, et al.
Breast Cancer Research and Treatment|October 12, 2013
Prospective clinical experience with research biopsies in breast cancer patientsInes Vaz-Luis, Catherine A Zeghibe, Elizabeth S Frank, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 12, 2022
Phase 1b Clinical Trial with Alpelisib plus Olaparib for Patients with Advanced Triple-Negative Breast CancerFelipe Batalini, Niya Xiong, Nabihah Tayob, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 19, 2022
Biomarkers for Adjuvant Endocrine and Chemotherapy in Early-Stage Breast Cancer: ASCO Guideline UpdateFabrice Andre, Nofisat Ismaila, Kimberly H Allison, et al.
NPJ Breast Cancer|August 21, 2024
Association between tumor-infiltrating lymphocytes and survival in patients with metastatic breast cancer receiving first-line chemotherapy: analysis of CALGB 40502Daniel G Stover, Roberto Salgado, Oleksander Savenkov, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 3, 2024
A Phase II Study of Atezolizumab, Pertuzumab, and High-Dose Trastuzumab for Central Nervous System Metastases in Patients with HER2-Positive Breast CancerAntonio Giordano, Priya U Kumthekar, Qingchun Jin, et al.
Pageof 12

Showing results (71-80 of 120) with videos related to

Sort By:
Pageof 12
Future Oncology (London, England)|April 18, 2023
Design of SERENA-6, a phase III switching trial of camizestrant in <i>ESR1</i>-mutant breast cancer during first-line treatmentNicholas Turner, Cynthia Huang-Bartlett, Kevin Kalinsky, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 20, 2014
Circulating tumor cell analysis in metastatic triple-negative breast cancersMark Jesus M Magbanua, Lisa A Carey, Amy DeLuca, et al.
Journal of Surgical Oncology|July 10, 2016
Immediate breast reconstruction following mastectomy in pregnant women with breast cancerDiana L Caragacianu, Erica L Mayer, Yoon S Chun, et al.
Journal of the American College of Cardiology|June 27, 2015
Cardiovascular Health of Patients With Cancer and Cancer Survivors: A Roadmap to the Next LevelAna Barac, Gillian Murtagh, Joseph R Carver, et al.
Breast Cancer Research and Treatment|March 7, 2026
A phase II study of atezolizumab in combination with stereotactic radiation for patients with triple-negative breast cancer and brain metastasisAntonio Giordano, Noah Graham, Ayal A Aizer, et al.
Breast Cancer Research and Treatment|October 12, 2013
Prospective clinical experience with research biopsies in breast cancer patientsInes Vaz-Luis, Catherine A Zeghibe, Elizabeth S Frank, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 12, 2022
Phase 1b Clinical Trial with Alpelisib plus Olaparib for Patients with Advanced Triple-Negative Breast CancerFelipe Batalini, Niya Xiong, Nabihah Tayob, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 19, 2022
Biomarkers for Adjuvant Endocrine and Chemotherapy in Early-Stage Breast Cancer: ASCO Guideline UpdateFabrice Andre, Nofisat Ismaila, Kimberly H Allison, et al.
NPJ Breast Cancer|August 21, 2024
Association between tumor-infiltrating lymphocytes and survival in patients with metastatic breast cancer receiving first-line chemotherapy: analysis of CALGB 40502Daniel G Stover, Roberto Salgado, Oleksander Savenkov, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 3, 2024
A Phase II Study of Atezolizumab, Pertuzumab, and High-Dose Trastuzumab for Central Nervous System Metastases in Patients with HER2-Positive Breast CancerAntonio Giordano, Priya U Kumthekar, Qingchun Jin, et al.
Pageof 12